コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
2 ances in the use of MOFs in the elimination (adsorption and/or degradation) of EOCs from water, classifying them by the n
3 which mimic the diabetic milieu, including high glucose and/or fatty levels, and by the ablation of genes associated with
4 Previous studies demonstrated that loss of function of ANK or ENPP1 (reducing PP(i)) resulted in increased cementum form
5 actice, particularly among patients with alcohol-associated or NASH-related cirrhosis and those not followed in subspecia
6 nitriles and alkynes, ring opening of 2-imino-2H-azirines, or direct metalation of 4-azadiene-1-amine derivatives.
7 The absence of PlexA1, neuronal activity, Bax and Bak, or caspase-9 leads to the maintenance of ipsilateral projecti
10 Total memory T-cell responses were measured after anti-CD3 or vaccinia virus (VV) stimulation to measure T cells elicite
11 d cultures of 24 pediatric patients undergoing chemotherapy or hematopoietic stem cell transplantation for hematological
12 without immune escape, tumor neoantigens are either clonal or at low frequency; hypermutated tumors can only establish a
13 es are strongly modulated by changes in cellular conditions or genetic context, the latter determined using a pairwise ge
14 Both scenarios facilitate range expansion, contraction or stability depending on the strength and the direction of t
16 tomic imaging tools such as echocardiography and cardiac CT or CT angiography are the first-line modalities for clinicall
17 gests that NPR1 is centrally integrated into the cell death or survival decisions in plant immunity by modulating multipl
19 out significantly affecting cell proliferation, cell death, or UPR induction in murine myeloblast 32D and human promyeloc
21 at blunt productive anti-tumor immune responses by directly or indirectly excluding effector CD8+ T cells from the tumor
22 brain disorders and injuries, e.g., in Parkinson's disease or traumatic brain injury (TBI), and hence it will be useful
24 OL heterogeneity might correlate with the local environment or their interactions with different neuron types.
25 or the development of new pharmacologic agents that exploit or target TMPRSS6 to treat anemias and iron-related diseases.
26 iation in several metabolite pools such as malate, fumarate or citrate, and flux calculations suggest the involvement of
27 is (HP) is hampered by variable presentation, heterogeneous or undetected causal antigens and lack of gold-standard bioma
28 ed blood pressure (systolic blood pressure level >140 mm Hg or diastolic blood pressure level >90 mm Hg), uncontrolled di
29 t manner, but did not change TSH levels, weight, histology, or expression of marker genes of the thyroid gland.
31 be performed at either 4 degrees C (in situ cooling [ISC]) or 33-36 degrees C (normothermic regional perfusion [NRP]).
32 electrodes are thinner and more flexible than typical metal or silicon electrodes, but the arrays described in previous r
36 manageable safety profile in patients with treatment-naive, or relapse or refractory Waldenstrom macroglobulinemia.
39 s of a transition metal (TM) ion assembly be it in proteins or in coordination complexes affords us a better understandin
40 safety profile in patients with treatment-naive, or relapse or refractory Waldenstrom macroglobulinemia.
42 ed mimetics did not change focal adhesion tension sensation or enrich for p38-YAP-TEAD interactions, which explains the t
44 associated with an increased incidence of recurrent stroke or TIA: 2.32 versus 0.75 events per 100 patient-years (hazard
45 nts were randomized 3:2 to suprachoroidally injected CLS-TA or sham treatment, with administrations at day 0 and week 12.
46 cate HBV (genotype D, serotype ayw)-either from a transgene or after infection with an adeno-associated virus that transf
47 ing rapid antimicrobial susceptibility tests with one, two, or even three antibiotics against two clinically isolated mul
48 Transplanted mice were treated with vehicle or di-n-butyl-phthalate (DBP, a plasticising chemical known t
50 eukotriene B4 (LTB4) in vitro after activation with zymosan or immune complexes, compared with wild-type (WT) neutrophils